Nexera Pharmaceuticals Announces Plans to Go Public on the New York Stock Exchange in August 2025
Toronto, Ontario and Chicago, Illinois – June 24, 2025 – Nexera Pharmaceuticals is excited to announce its intention to go public with a listing on the
Blog
Blog
Nexera Pharmaceuticals Achieves Public Reimbursement for Trecondy
22 June 2024-Quebec Nexera Pharmaceuticals (TSX: NEX) has announced the successful completion of a listing agreement with the Government of Quebec for Trecondy® (treosulfan for